Aridis Pharmaceuticals Inc (ARDS)
0.0615
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Aridis Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.3172 |
| March 31, 2023 | -0.0806 |
| December 31, 2022 | -0.1775 |
| September 30, 2022 | -0.3385 |
| June 30, 2022 | -0.391 |
| March 31, 2022 | -0.5285 |
| December 31, 2021 | -0.456 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.0836 |
| December 31, 2020 | -0.0824 |
| September 30, 2020 | -0.0633 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1177 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.5285
Minimum
Mar 2022
--
Maximum
Jun 2019
-0.1551
Average
-0.0824
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.534M |
| Total Liabilities (Quarterly) | 18.34M |
| Shareholders Equity (Quarterly) | -11.80M |